You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

plx3397

Showing 1 - 14 of 14
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Melanoma Trial in Beijing, Guangzhou, Seoul (PLX3397)

Active, not recruiting
Has Results
  • Melanoma
  • PLX3397
  • Beijing, Beijing, China
  • +4 more
Apr 21, 2022

Sarcoma, Malignant Peripheral Nerve Sheath Tumors Trial in United States (PLX3397, Sirolimus)

Recruiting
  • Sarcoma
  • Malignant Peripheral Nerve Sheath Tumors
  • Iowa City, Iowa
  • +4 more
Aug 26, 2021

Solid Tumor Trial in United States (PLX3397)

Completed
Has Results
  • Solid Tumor
  • PLX3397
  • Scottsdale, Arizona
  • +12 more
Dec 6, 2021

Malignant Melanoma Trial in United Kingdom (PLX3397)

Completed
  • Malignant Melanoma
  • PLX3397
  • Manchester, Greater Manchester, United Kingdom
  • +7 more
Aug 11, 2021

Metastatic Breast Cancer Trial in San Francisco, Durham, Nashville (PLX3397, Eribulin)

Completed
Has Results
  • Metastatic Breast Cancer
  • San Francisco, California
  • +2 more
Jul 2, 2020

Hodgkin Lymphoma Trial in United States (PLX3397)

Completed
Has Results
  • Hodgkin Lymphoma
  • PLX3397
  • Los Angeles, California
  • +5 more
Jun 18, 2020

Solid Tumors Trial in United States (PLX3397, Paclitaxel)

Completed
Has Results
  • Solid Tumors
  • Birmingham, Alabama
  • +7 more
Jul 14, 2020

Patients With Newly Diagnosed Glioblastoma Trial in United States (PLX3397, Radiation Therapy, Temozolomide)

Completed
Has Results
  • Patients With Newly Diagnosed Glioblastoma
  • PLX3397
  • +2 more
  • Chicago, Illinois
  • +8 more
Jun 19, 2020

Prostate Cancer Trial in Boston, New York (PLX3397)

Terminated
Has Results
  • Prostate Cancer
  • PLX3397
  • Boston, Massachusetts
  • +1 more
Feb 18, 2020

V600-mutated BRAF Unresectable Melanoma, V600-mutated BRAF Metastatic Melanoma, Stage III or Stage IV Metastatic Melanoma That

Terminated
Has Results
  • V600-mutated BRAF Unresectable Melanoma
  • +2 more
  • Los Angeles, California
  • +5 more
May 12, 2020

Acute Myeloid Leukemia Trial in United States (PLX3397)

Completed
Has Results
  • Acute Myeloid Leukemia
  • PLX3397
  • San Francisco, California
  • +8 more
Feb 18, 2020

Melanoma, NSCLC, Squamous Cell Carcinoma of the Head and Neck Trial in United States (PLX3397, Pembrolizumab)

Terminated
Has Results
  • Melanoma
  • +4 more
  • PLX3397
  • Pembrolizumab
  • Scottsdale, Arizona
  • +11 more
Feb 18, 2020

Breast Tumors, Breast Cancer, Breast Tumors Trial in United States (Standard Therapy, AMG 386 with or without Trastuzumab, AMG

Recruiting
  • Breast Neoplasms
  • +10 more
  • Standard Therapy
  • +32 more
  • Birmingham, Alabama
  • +35 more
Nov 17, 2022

Rheumatoid Arthritis Trial in United States (PLX3397)

Withdrawn
  • Rheumatoid Arthritis
  • PLX3397
  • Tuscaloosa, Alabama
  • +4 more
Mar 13, 2015